Cargando…
DPP-4 inhibition with linagliptin ameliorates the progression of premature aging in klotho−/− mice
BACKGROUND: The potential of anti-aging effect of DPP-4 inhibitors is unknown. This study was performed to determine whether linagliptin, a DPP-4 inhibitor, could protect against premature aging in klotho−/− mice. METHODS: Klotho−/− mice exhibit multiple phenotypes resembling human premature aging,...
Autores principales: | Hasegawa, Yu, Hayashi, Kenyu, Takemoto, Yushin, Cheng, Cao, Takane, Koki, Lin, Bowen, Komohara, Yoshihiro, Kim-Mitsuyama, Shokei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5709858/ https://www.ncbi.nlm.nih.gov/pubmed/29195509 http://dx.doi.org/10.1186/s12933-017-0639-y |
Ejemplares similares
-
DPP-4 inhibition with linagliptin ameliorates cognitive impairment and brain atrophy induced by transient cerebral ischemia in type 2 diabetic mice
por: Ma, MingJie, et al.
Publicado: (2015) -
DPP-4 inhibitor linagliptin ameliorates cardiovascular injury in salt-sensitive hypertensive rats independently of blood glucose and blood pressure
por: Koibuchi, Nobutaka, et al.
Publicado: (2014) -
High‐Fat‐Diet Intake Enhances Cerebral Amyloid Angiopathy and Cognitive Impairment in a Mouse Model of Alzheimer's Disease, Independently of Metabolic Disorders
por: Lin, Bowen, et al.
Publicado: (2016) -
Detrimental Effects of Centrally Administered Angiotensin II are Enhanced in a Mouse Model of Alzheimer Disease Independently of Blood Pressure
por: Takane, Koki, et al.
Publicado: (2017) -
Glycemic control with empagliflozin, a novel selective SGLT2 inhibitor, ameliorates cardiovascular injury and cognitive dysfunction in obese and type 2 diabetic mice
por: Lin, Bowen, et al.
Publicado: (2014)